Tianyuan Environmental Protection and Huawei signed a strategic cooperation agreement, and Tianyuan Environmental Protection and Huawei signed a strategic cooperation agreement in Shenzhen. According to the agreement, Tianyuan Environmental Protection and Huawei will adhere to the principle of "complementary advantages, mutual benefit and win-win, long-term cooperation and common development" and explore innovative cooperation paths around intelligent optical storage, low-carbon artificial intelligence intelligent calculation, digital construction and application of comprehensive smart energy. In the development of large-scale photovoltaic and energy storage projects, the two sides will build a national-level "photovoltaic intelligent operation and maintenance" demonstration benchmark and explore a grid-type energy storage application model project. By establishing a long-term and stable all-round cooperative relationship, we will deepen cooperation and exchanges and promote the high-quality development of the industry. (Tianyuan Environmental Protection) Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
In 2024, the rating of brokerage investment banking business is nearing the end, and the results of 96 brokers will be released. The reporter was informed that the quality evaluation of brokerage investment banking business in 2024 is nearing the end, and the evaluation scores of investment banking business quality of 96 participating brokers in 2024 have been distributed to companies. After the brokers confirm, the association will start the formal scoring work. In September this year, the China Securities Association launched the quality evaluation of brokerage investment banking business in 2024, and initially determined the participating brokerage and investment banking projects. According to the preliminary statistics, about 68 brokers are expected to get extra points for supporting high-level science and technology in investment banking. (Cailian)Afternoon comment: the three major indexes rose slightly in half a day, and the concept of Shanghai's state-owned enterprise reform lifted the tide of daily limit. The three major indexes opened lower and went higher in early trading and rose slightly in half a day. In terms of sectors, the concept of Shanghai's state-owned enterprise reform is on the rise, and Shanghai Material Trade, First Medicine and Shibei High-tech are collectively on the rise. The retail sector continued to be strong, with the daily limit of Youa, Zhongbai Group and Maoye Commercial. The concept of AI glasses is higher, and Tianjian shares and Star Technology both have a daily limit of 20cm; Insurance stocks continued to adjust, and Tianmao Group fell to an intraday limit; Sora concept stocks collectively adjusted back, and the word Huayang Lianzhong fell; Bank shares fluctuated lower, with Bank of Ningbo leading the decline. Overall, stocks rose more and fell less, with more than 3,500 stocks rising. On the disk, Shanghai's state-owned enterprise reform, AI glasses and retail sectors were among the top gainers, while insurance, Sora concept and banking sectors were among the top losers.Shanghai Ailu: Signed the Strategic Cooperation Agreement with Huaneng New Energy. Shanghai Ailu (301062) announced on the evening of December 11th and signed the Strategic Cooperation Agreement with Huaneng New Energy: Huaneng New Energy will combine the technological research and development and industrial introduction advantages of the company and its holding subsidiary Aina New Energy, and conduct business transactions on the "glass fiber reinforced polyurethane composite frame" products independently developed by Aina New Energy, and through product procurement and technical exchange.
Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.Yonhap News Agency: South Korean Prime Minister Han Dezhu blamed himself for failing to stop martial law.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide